Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Still Bullish After All These Years


Q: Which biotechs look good now?

A: I think on a long-term basis both Amgen (AMGN ) and Genentech (DNA ) can be included in a portfolio, despite the fact that the valuations are relatively high. Johnson & Johnson (JNJ ) continues to impress me as a company transitioning to higher market products, not just in biotech but also in devices. Clearly, the scientific component of their product portfolio is getting stronger. It won't surprise me if the stock hits a new high today.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus